Bulletin
Investor Alert

New York Markets Open in:

Zynerba Pharmaceuticals Inc.

NAS: ZYNE

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/204500323/composite

$

3.54

Change

-0.05 -1.39%

Volume

Volume 5,916

Jan 28, 2021, 8:58 a.m.

Real time quotes

/zigman2/quotes/204500323/composite

Previous close

$ 3.59

$ 3.59

Change

+0.04 +0.98%

Day low

Day high

$3.41

$3.65

Open
Open: 3.53

52 week low

52 week high

$2.55

$7.45

Open

Market cap

$104.66M

Average volume

1.09M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.08

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/zyne

MarketWatch News on ZYNE

  1. How to make, and avoid losing, money with marijuana stocks

    2:01 p.m. July 24, 2018

    - Nigam Arora

  2. Tech rally leads stocks higher; trade and Fed minutes also in focus

    3:27 p.m. July 5, 2018

    - Barbara Kollmeyer

  3. Zynerba says it now has enough cash to last until second half of 2019

    6:36 a.m. July 5, 2018

    - Ciara Linnane

  4. Zynerba shares slide 4.6% premarket

    6:36 a.m. July 5, 2018

    - Ciara Linnane

  5. Zynerba Pharma says study of cannabinoid skin patch did not meet goals

    6:35 a.m. July 5, 2018

    - Ciara Linnane

  6. Zynerba will now focus efforts on epilepsy program

    6:36 a.m. July 5, 2018

    - Ciara Linnane

  7. Zynerba Pharmaceuticals downgraded to perform from outperform at Oppenheimer

    6:57 a.m. Aug. 15, 2017

    - Tomi Kilgore

  8. Zynerba Pharmaceuticals downgraded to hold from buy at Maxim Group

    12:44 p.m. Aug. 7, 2017

    - Tomi Kilgore

  9. GW Pharma shares surge 2.7% after Zynerba Pharma's failed cannabidiol gel trial

    8:38 a.m. Aug. 7, 2017

    - Emma Court

  10. Zynerba's stock on track to open at lowest level since June 2016

    7:33 a.m. Aug. 7, 2017

    - Tomi Kilgore

  11. Zynerba's stock volume tops 600,000 shares premarket, already above full-day average of 590,000

    7:22 a.m. Aug. 7, 2017

    - Tomi Kilgore

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/zyne

Other News on ZYNE

  1. Zeroing In On Zynerba Pharmaceuticals

    5:33 p.m. Jan. 25, 2021

    - Seeking Alpha

  2. Cannabis In California Will Boom Into A Powerhouse Opportunity

    5:52 p.m. Jan. 24, 2021

    - Seeking Alpha

  3. The 20 Most Undervalued Cannabis Stocks

    8:42 a.m. Dec. 21, 2020

    - Seeking Alpha

  4. MARA, NXTD, ZYNE and SCYX among midday movers

    12:41 p.m. Dec. 17, 2020

    - Seeking Alpha

  5. CureVac, Triterras leads premarket losers' pack

    8:23 a.m. Dec. 17, 2020

    - Seeking Alpha

  6. Cannabis Stocks Are Hot Again And Here Are Some You Should Buy

    3:57 p.m. Dec. 14, 2020

    - Seeking Alpha

  7. Seeking Alpha Catalyst Watch

    3:30 p.m. Nov. 20, 2020

    - Seeking Alpha

  8. 10-Q: ZYNERBA PHARMACEUTICALS, INC.

    7:33 a.m. Nov. 9, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Zynerba Pharmaceuticals EPS beats by $0.12

    6:51 a.m. Nov. 9, 2020

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/zyne

Press Releases on ZYNE

  1. Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc.

    3:49 p.m. Dec. 9, 2020

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.